Cognitive and Perceptual Factors, Not Disease Severity, Are Linked with Anxiety in COPD: Results from a Cross-Sectional Study

International Journal of Behavioral Medicine

Volumn 25, Issue 1, 2018, Pages 74-84

  Thakur, Elyse R ^a,b,c   Sansgiry, Shubhada ^a,b,c   Petersen, Nancy J ^a,b   Stanley, Melinda ^a,b,c   Kunik, Mark E ^a,b,c   Naik, Aanand D ^a,b   Cully, Jeffrey A ^a,b,c  

^a MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c EDUCATION AND CLINICAL CENTER   (United States)

Author keywords

Comorbid conditions; COPD; Coping; Locus of control; Mental health; Veterans

Indexed keywords

AGED; ANXIETY; CHRONIC OBSTRUCTIVE LUNG DISEASE; COGNITION; COMORBIDITY; COMPLICATION; COPING BEHAVIOR; CROSS-SECTIONAL STUDY; ETIOLOGY; FATIGUE; FEMALE; HUMAN; MALE; MIDDLE AGED; OUTPATIENT; PSYCHOLOGY; QUALITY OF LIFE; QUESTIONNAIRE; SELF CONCEPT; VETERAN;

ADAPTATION, PSYCHOLOGICAL; AGED; ANXIETY; COGNITION; COMORBIDITY; CROSS-SECTIONAL STUDIES; FATIGUE; FEMALE; HUMANS; MALE; MIDDLE AGED; OUTPATIENTS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; SELF EFFICACY; SURVEYS AND QUESTIONNAIRES; VETERANS;

EID: 85026847567     PISSN: 10705503     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12529-017-9663-2     Document Type: Article

References (60)

1. Buist AS, MA MB, Vollmer WM, Gillespie S, Burney P, Mannino DM, et al. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet. 2007;370(9589):741–50.
2. Jemal A, Ward E, Hao Y, Thun M. Trends in the leading causes of death in the United States, 1970-2002. JAMA. 2005;294(10):1255–9.
3. Yohannes AM, Alexopoulos GS. Depression and anxiety in patients with COPD. Eur Respir Rev. 2014;23(133):345–9.
4. Pauwels RA, Rabe KF. Burden and clinical features of chronic obstructive pulmonary disease (COPD). Lancet. 2004;364(9434):613–20.
5. Brenes GA. Anxiety and chronic obstructive pulmonary disease: prevalence, impact, and reatment. Psychosom Med. 2003;65(6):963–70.
6. Kunik ME, Roundy K, Veazey C, Souchek J, Richardson P, Wray NP, et al. Surprisingly high prevalence of anxiety and depression in chronic breathing disorders. Chest. 2005;127(4):1205–11.
7. Yohannes AM, Willgoss TG, Baldwin RC, Connolly MJ. Depression and anxiety in chronic heart failure and chronic obstructive pulmonary disease: prevalence, relevance, clinical implications and management principles. Int J Geriatr Psychiatry. 2010;25(12):1209–21.
8. Aydin IO, Uluşahin A. Depression, anxiety comorbidity, and disability in tuberculosis and chronic obstructive pulmonary disease patients: applicability of GHQ-12. Gen Hosp Psychiatry. 2001;23(2):77–83.
9. Maurer J, Rebbapragada V, Borson S, Goldstein R, Kunik ME, Yohannes AM, et al. Anxiety and depression in COPD. Current understanding, unanswered questions, and research needs. Chest. 2008;134(4 Suppl):43S–56S.
10. Gudmundsson G, Gislason T, Janson C, Lindberg E, Hallin R, Ulrik CS, et al. Risk factors for rehospitalisation in COPD: role of health status, anxiety and depression. Eur Respir J. 2005;26(3):414–9.
11. Yellowlees PM, Alpers JH, Bowden JJ, Bryant GD, Ruffin RE. Psychiatric morbidity in patients with chronic airflow obstruction. Med JAust. 1987;46(6):305–7.
12. Mikkelsen RL, Middelboe T, Pisinger C, Stage KB. Anxiety and depression in chronic obstructive pulmonary disease (COPD). A review Nord J Psychiatry. 2004;58(1):65–70.
13. Cully JA, Graham DP, Stanley MA, Ferguson CJ, Sharafkhaneh A, Souchek J, et al. Quality of life in patients with chronic obstructive pulmonary disease and comorbid anxiety or depression. Psychosomatics. 2006;47(4):312–9.
14. Meek PM, Lareau SC. Critical outcomes in pulmonary rehabilitation: assessment and evaluation of dyspnea and fatigue. J Rehabil Res Dev. 2003;40(5 Suppl 2):13–24.
15. Harver A, Mahler DA. Dyspnea: sensation, symptom, and illness. Lung Biol Health Dis. 1998;111:1–33.
16. Felker B, Bush KR, Harel O, Shofer JB, Shores MM, Au DH. Added burden of mental disorders on health status among patients with chronic obstructive pulmonary disease. Prim Care Companion J Clin Psychiatry. 2010;12(4).
17. Coultas DB, Edwards DW, Barnett B, Wludyka P. Predictors of depressive symptoms in patients with COPD and health impact. COPD. 2007;4(1):23–8.
18. Paukert AL, Lemaire A, Cully JA. Predictors of depressive symptoms in older veterans with heart failure. Aging Ment Health. 2009;13(4):601–10.
19. Devins GM, Bezjak A, Mah K, Loblaw DA, Gotowiec AP. Context moderates illness-induced lifestyle disruptions across life domains: a test of the illness intrusiveness theoretical framework in six common cancers. Psyco-Oncology. 2006;15(3):221–33.
20. Shuster J, McCormack J, Riddell RP, Toplak ME. Understanding the psychosocial profile of women with fibromyalgia syndrome. Pain Res Manag. 2009;14(3):239–45.
21. Wallston KA, Wallston BS, Smith S, Dobbins CJ. Perceived control and health. Curr Psychol: Res Rev. 1987;6:5–25.
22. Edwards R, Telfair J, Cecil H, Lenoci J. Self-efficacy as a predictor of adult adjustment to sickle cell disease: one-year outcomes. Psychosom Med. 2001;63(5):850–8.
23. Lee H, Young Yoon J, Kim I, Young-Hee J. The effects of personal resources and coping strategies on depression and anxiety in patients with chronic obstructive pulmonary disease. Heart Lung. 2013;42(6):473–9.
24. Simpson E, Jones MC. An exploration of self-efficacy and self-management in COPD patients. Br J Nurs. 2013;22(19):1105–9.
25. Breland JY, Hundt NE, Barrera TL, Mignogna J, Petersen NJ, Stanley MA, et al. Identification of anxiety symptom clusters in patients with COPD: implications for assessment and treatment. Int J Behav Med. 2015;22(5):1–7.
26. Scharloo M, Kaptein AA, Weinman JA, Willems LNA, Rooijmans HGM. Physical and psychological correlates of functioning in patients with chronic obstructive pulmonary disease. J Asthma. 2000;37(1):17–29.
27. Stoilkova A, Janssen DJ, Franssen FM, Spruit MA, Wouters EF. Coping styles in patients with COPD before and after pulmonary rehabilitation. Respir Med. 2013;107(6):825–33.
28. McCathie HCF, Spence SH, Tate RL. Adjustment to chronic obstructive pulmonary disease: the importance of psychological factors. Eur Respir J. 2002;19(1):47–53.
29. Lazarus RS, Folkman S. Stress, appraisal, and coping. New York: Springer; 1984.
30. Englbrecht M, Gossec L, DeLongis A, Scholte-Voshaar M, Sokka T, Kvien TK, et al. The impact of coping strategies on mental and physical well-being in patients with rheumatoid arthritis. Semin Arthritis Rheum. 2012;41(14):545–55.
31. Cully JA, Armento ME, Mott J, Nadorff MR, Naik AD, Stanley MA, et al. Brief cognitive behavioral therapy in primary care: a hybrid type 2 patient-randomized effectiveness implementation design. Implement Sci. 2012;7:64.
32. Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999;54(7):581–6.
33. Spitzer RL, Williams JB, Kroenke K, Linzer M, de Gruy FV 3rd, Hahn SR, et al. Utility of a new procedure for diagnosing mental disorders in primary care: the PRIME-MD 1000 study. JAMA. 1994;272(22):1749–56.
34. Guyatt GH, Berman LB, Townsend M, Pugsley SO, Chambers LW. A measure of quality of life for clinical trials in chronic lung disease. Thorax. 1987;42(10):773–8.
35. Devins GM, Binik YM, Hutchinson TA, Hollomby DJ, Barre PE, Guttmann RD. The emotional impact of end-stage renal disease: importance of patients’ perceptions of intrusiveness and control. Int J Psychiatry Med. 1983;13(4):327–43.
36. Wallston KA, Stein MJ, Smith CA. Form C of the MHLC scales: a condition-specific measure of locus of control. J Pers Assess. 1994;63(3):534–53.
37. Lorig K, Stewart A, Ritter P, Gonzalez V, Laurent D, Lynch J. Outcome measures for health education and other health care interventions. Thousand Oaks: Sage Publications; 1996.
38. Carver CS. You want to measure coping but your protocol’s too long: consider the brief COPE. Int J Behav Med. 1997;4(1):92–100.
39. Beck A, Steer R. Beck anxiety inventory manual. San Antonio: Harcourt Brace and Company; 1990.
40. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606–13.
41. Ries AL. Impact of chronic obstructive pulmonary disease on quality of life: the role of dyspnea. Am J Med. 2006;119(10 Suppl 1):12–20.
42. Reardon JZ, Lareau SC, ZuWallack R. Functional status and quality of life in chronic obstructive pulmonary disease. Am J Med. 2006;119(10 Suppl 1):32–7.
43. Bendel RB, Afifi A. Comparison of stopping rules in forward regression. J Am Stat Assoc. 1977;72:46–53.
44. Hundt NE, Amspoker AB, Kraus-Schuman C, Cully JA, Rhoades H, Kunik ME, et al. Predictors of CBt outcome in older adults with GAD. J Anxiety Disord. 2014;28(8):845–50.
45. Barrera TL, Cully JA, Amspoker AB, Wilson NL, Kraus-Schuman C, Wagener PD, et al. Cognitive-behavioral therapy for late-life anxiety: similarities and differences between veteran and community participants. J Anxiety Disord. 2015;33:72–80.
46. Asadi-Pooyab AA, Schilling CA, Glosser D, Tracy JI, Sperling MR. Health locus of control in patients with epilepsy and its relationship to anxiety, depression, and seizure control. Epilepsy Behav. 2007;11(3):347–50.
47. Carver CS, Connor-Smith J. Personality and coping. Annu Rev Psychol. 2010;61:679–704.
48. Van Ede L, Yzermans CJ, Brouwer HJ. Prevalence of depression in patients with chronic obstructive pulmonary disease: a systematic review. Thorax. 1999;54(8):688–92.
49. McAndrew LM, Musumeci-Szabó TJ, Mora PA, Vileikyte L, Burns E, Halm EA, et al. Using the common sense model to design interventions for the prevention and management of chronic illness threats: from description to process. B J Health Psychol. 2008;13(2):195–204.
50. Scharloo M, Kaptein AA, Weinman J, Hazes JM, Willems LN, Bergman W, et al. Illness perceptions, coping and functioning in patients with rheumatoid arthritis, chronic obstructive pulmonary disease and psoriasis. J Psychosom Res. 1998;44(5):573–l85.
51. Scharloo M, Kaptein AA, Schlösser M, Pouwels H, Bel CH, Rabe KF, et al. Illness perceptions and quality of life in patients with chronic obstructive pulmonary disease. J Asthma. 2007;44(7):575–81.
52. Vaske I, Kenn K, Keil DC, Rief W, Stenzel NM. Illness perceptions and coping with disease in chronic obstructive pulmonary disease: effects on health-related quality of life. J Health Psychol. 2016.
53. Zoeckler N, Kenn K, Kuehl K, Stenzel N, Rief W. Illness perceptions predict exercise capacity and psychological well-being after pulmonary rehabilitation in COPD patients. J Psychosom Res. 2014;76(2):146–51.
54. De Peuter S, Janssens T, Van Diest I, Stans L, Troosters T, Decramer M, et al. Dyspnea-related anxiety: the Dutch version of the breathlessness beliefs questionnaire. Chron Respir Dis. 2011;8(1):11–9.
55. Keil DC, Stenzel NM, Kühl K, Vaske I, Mewes R, Rief W, et al. The impact of chronic obstructive pulmonary disease-related fears on disease-specific disability. Chron Respir Dis. 2014;11(1):31–40.
56. Janssens T, De Peuter S, Stans L, Verleden G, Troosters T, Decramer M, et al. Dyspnea perception in COPD: association between anxiety, dyspnea-related fear, and dyspnea in a pulmonary rehabilitation program. Chest. 2011;140(3):618–25.
57. Heslop-Marshall K, De Soyza A. Are we missing anxiety in people with chronic obstructive pulmonary disease (COPD)? Ann Depress Anxiety. 2014;1:1023.
58. Usmani ZA, Carson KV, Cheng JN, Esterman AJ, Smith BJ. Pharmacological interventions for the treatment of anxiety disorders in chronic obstructive pulmonary disease. The Cochrane Library. 2011.
59. Cully JA, Paukert A, Falco J, Stanley M. Cognitive-behavioral therapy: innovations for cardiopulmonary patients with depression and anxiety. CognBehav Pract. 2009;16:394–407.
60. Cully JA, Stanley MA, Deswal A, Hanania NA, Phillips LL, Kunik ME. Cognitive-behavioral therapy for chronic cardiopulmonary conditions: preliminary outcomes from an open trial. Prim Care Companion J Clin Psychiatry. 2010;12(4).